New combo therapy aims to boost rectal cancer survival

NCT ID NCT04643366

First seen Jan 31, 2026 · Last updated May 19, 2026 · Updated 12 times

Summary

This study is testing a treatment plan for people with rectal cancer that can be surgically removed. Participants receive a combination of chemotherapy (mFOLFOX) and a short course of radiation before surgery. The goal is to see if this approach improves the chance of being cancer-free three years later.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VCU Community Memorial Healthcenter

    RECRUITING

    South Hill, Virginia, 23970, United States

    Contact Email: •••••@•••••

  • Virginia Cancer Institute

    RECRUITING

    Richmond, Virginia, 23230, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Virginia Commonwealth University Massey Cancer Center

    RECRUITING

    Richmond, Virginia, 23298, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.